Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea
· Delayed Price · Currency is KRW 65,300
+2,500 (3.98%)
At close: Mar 6, 2026
Aimed Bio Company Description
Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX).
Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea.
Aimed Bio Inc.
| Country | South Korea |
| Founded | 2018 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Nam-Gu Her |
Contact Details
Address: 10F 11F MK Tower Seoul, 05835 South Korea | |
| Phone | 82 2 6285 0743 |
| Website | aimedbio.com |
Stock Details
| Ticker Symbol | 0009K0 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Nam-Gu Her | Chief Executive Officer |
| Munyeong Huh | Chief Financial Officer |
| Taekyoung Kim | Chief Operating Officer |